The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Blimey Regulator. You are practically a gambler! Well, at least you are on a winning streak as my Seychelloise granny would say.
I regret not getting any SNG. Reckon I will look at them for an option on moving my pension into a shares SIPP. Though there's going to be no point having cash by the middle of next year if they introduce negative interest rates.
I think VAST, delivering enhanced JORC and first concentrate sale over the next few days, is a non covid share to have some exposure in. Currently around. 19p, will bag.
All penny shares chasing fantasies. Plummeting too. IMM looks well scary. N4P hilarious. Got nowt but going ahead with nowt because investors funding them. At least VAL once had cancer uk involved but that was a long time ago. Amazing what people invest in when we are sitting on a dead cert bagger here. Interesting. I guess if people tolerate that much volatility which always leaves a lot of losers, no wonder people get impatient when you get a pretty stable mover like this. As soon as we get either the immunity report or MHRA approval, though I think the former will preceed the latter, we will get big investors in to replace Sneller and we will get to another level and just keep building nicely as sales flood in. In terms of 'spreading risk' I don't like much risk at all tbh. That's why I am in here. I notice on those penny share boards there's always a lot of talk about 'the weak'. Macho bull****. I'd rather be 100+% in profit, looking forward to bagging again.
TILS - with the split in just over a week could be a nice (quick ) profit to be made - or longer term a bigger profit if you can cope with a bumpy ride. But being in ODX im guessing you can lol
"I checked out N4P because Regulator keeps mentioning it."
N4P's one of my 'pocket change' investments... I think it has some long term potential but I never invest what I can't easily afford to lose.
BRH is another of my educated gambles. I've done quite well on it to date and even sold some off to purchase some additional ODX. I'll probably sell of a few more and but some RMS for the fun of it.
N4P, BRH, RMS all have very low market cap with huge potential.
N4P in vivo trial for Nuvec - vaccine delivery system and testing it on covid vaccines that would not requite an injection. oral administration which come be a game changer. Not just a game changer for covid but other vaccines moving forward. If successful their tiny Mcap will multiply.
BRH have the antigen covid test which takes 5 minutes to get results and has had successful test results - not moving into next set of trials and discussing the test with potential purchasers. They also have investment in Pharm2farm who have results coming shortly for a face mask which kills the virus - again a game changer and also have preliminary orders for 1million in january.
RMS are buying pharm2farm from BRH so again they have great potential. BRH will end up owning shares in RMS as part of the deal so both companies will benefit from the masks once good news lands......
All 3 worth a look and potential multi baggers.
Obviously all 3 come with risks so worth spreading money between all of them IMO.
VAL are mad. Thx for your tips. Sorry for changing the subject. Don't think much of most of those. Will take a look at a few. I want something to get in and out of because I am going to commit the cardinal sin and go in 100% here by next Wednesday.
I am in IMM news expected around 9 September still waiting for the FDA. It is a stable share at the moment but on positive news it could well double
HEMO, SNG, VAL, IMM
RMS
Trickymatters...if you like pharma-related stocks, take a look at BRH, SAR, HEMO & 4D. Good things going on with all of them atm.
Boom is worth a gander as a Covid play. Not a pharma / biotech though.
Got another £15k to invest from something else I sold. Apart from NCYT there's really not a lot worth looking at in the stock market except ODX. I checked out N4P because Regulator keeps mentioning it. They've got bugger all. They've just done a pre pilot which yielded no results. Zip. No impact. But neither did the control group?!? So they're going ahead with a pilot because the control group got nothing either! Classic pump n'dump. Investors will be left holding the baby.
Might do Marston's for a week until the Carlsberg dosh comes in. Been tipped by the Times and Nils P in the Guardian business. Then bring it all here with the profits just in time for the investors presentation when we see what's what. I am expecting very good news. ODX always delivers.